Identification of the transcription factor MAZ as a regulator of erythropoiesis

Darya Deen, Falk Butter , Deborah Daniels, Ivan Ferrer-Vicens, Douglas Vernimmen, David Garrick, Michelle L. Holland, Vasiliki Samara, Jacqueline A. Sloane-Stanley, Helena Ayyub, Matthias Mann, Jan Frayne, Daniel Ferguson

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Erythropoiesis requires a combination of ubiquitous and tissue-specific transcription factors. Here, through DNA affinity purification followed by mass spectrometry, we have identified the widely expressed protein MAZ (Myc-associated zinc finger) as a transcription factor that binds to the promoter of the erythroid-specific human α-globin gene. Genome-wide mapping in primary human erythroid cells revealed that MAZ also occupies active promoters as well as GATA1-bound enhancer elements of key erythroid genes. Consistent with an important role during erythropoiesis, knockdown of MAZ reduces α-globin expression in K562 cells and impairs erythroid differentiation in primary human erythroid cells. Genetic variants in the MAZ locus are associated with changes in clinically important human erythroid traits. Taken together, these findings reveal the Zinc-finger transcription factor MAZ to be a previously unrecognised regulator of the erythroid differentiation program.
Original languageEnglish
Pages (from-to)3002-3015
Number of pages14
JournalBlood Advances
Early online date10 Aug 2021
Publication statusE-pub ahead of print - 10 Aug 2021


Dive into the research topics of 'Identification of the transcription factor MAZ as a regulator of erythropoiesis'. Together they form a unique fingerprint.

Cite this